<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02877758</url>
  </required_header>
  <id_info>
    <org_study_id>TMRW-CTa</org_study_id>
    <nct_id>NCT02877758</nct_id>
  </id_info>
  <brief_title>Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging</brief_title>
  <acronym>REDUCEAGE</acronym>
  <official_title>Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging - A Randomized Controlled Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tomorrowlabs GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tomorrowlabs GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tomorrowlabs has developed a revolutionary cosmeceutical formulation to rejuvenate aging
      skin. Tomorrowlabs is conducting this research to study whether this cosmeceutical can reduce
      the visible signs of cutaneous aging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is proposed to study a cosmeceutical formulation designed to reduce the visible signs of
      cutaneous aging. It is expected that daily application of the formulation may minimize
      wrinkles and fine lines of the face.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Validated Assessment Scales for Age-related Changes of the Face</measure>
    <time_frame>3 months</time_frame>
    <description>A reliable tool for valid and reproducible assessment of the aging process in various face areas will be employed by our independent panel of assessors to scale the primary outcome. (1-3)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin quality assessment</measure>
    <time_frame>3 months</time_frame>
    <description>The skin scope uses black light and magnification to show variety of skin imperfections that are undetectable with the naked eye such as dry and thin skin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction With the Results</measure>
    <time_frame>3 months</time_frame>
    <description>Self assessment questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tomorrowlabs cosmeceutical formulation is applied to the face of the subjects twice daily for 3 consecutive months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Tomorrowlabs cosmeceutical formulation without the active ingredient is applied to the face of the subjects twice daily for 3 consecutive months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tomorrowlabs cosmeceutical formulation</intervention_name>
    <arm_group_label>Experimental</arm_group_label>
    <other_name>HSF Cellular Age Reversal and Repair</other_name>
    <other_name>HSF Day Catalyst</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham cosmeceutical formulation</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers who desire to improve their appearance by reducing the visible
             signs of cutaneous aging in the face

        Exclusion Criteria:

          -  Subjects who have undergone facial plastic surgery or aesthetic dermatology treatments
             to the face (such as fillers and neuromodulators) in the past 6 months

          -  Subjects with a history of collagen vascular disease, cutis laxa, connective tissue
             disease, psoriasis, or lupus.

          -  Subjects diagnosed with scleroderma.

          -  Subjects with a body mass index (BMI) &gt; 30.

          -  Subjects taking steroid therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raphael Wenny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>JKU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominik Thor, PhD</last_name>
    <phone>+4369911917515</phone>
    <email>dominik@thor.at</email>
  </overall_contact>
  <reference>
    <citation>Narins RS, Carruthers J, Flynn TC, Geister TL, Görtelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, de Maio M, Mohrmann C, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated assessment scales for the lower face. Dermatol Surg. 2012 Feb;38(2 Spec No.):333-42. doi: 10.1111/j.1524-4725.2011.02247.x.</citation>
    <PMID>22316189</PMID>
  </reference>
  <reference>
    <citation>Carruthers J, Flynn TC, Geister TL, Görtelmeyer R, Hardas B, Himmrich S, Jones D, Kerscher M, de Maio M, Mohrmann C, Narins RS, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Breitscheidel L, Carruthers A. Validated assessment scales for the mid face. Dermatol Surg. 2012 Feb;38(2 Spec No.):320-32. doi: 10.1111/j.1524-4725.2011.02251.x.</citation>
    <PMID>22316188</PMID>
  </reference>
  <reference>
    <citation>Flynn TC, Carruthers A, Carruthers J, Geister TL, Görtelmeyer R, Hardas B, Himmrich S, Kerscher M, de Maio M, Mohrmann C, Narins RS, Pooth R, Rzany B, Sattler G, Buchner L, Benter U, Fey C, Jones D. Validated assessment scales for the upper face. Dermatol Surg. 2012 Feb;38(2 Spec No.):309-19. doi: 10.1111/j.1524-4725.2011.02248.x.</citation>
    <PMID>22316187</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>August 23, 2016</last_update_submitted>
  <last_update_submitted_qc>August 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cutaneous aging</keyword>
  <keyword>skin rejuvenation</keyword>
  <keyword>wrinkles</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

